Evaluating Sex-Biased Adverse Event-Associated Drugs to Improve Kidney Disease Drug Prioritization TH-PO116

Leukocytes telomere length as a biomarker of adverse drug reactions induced by Osimertinib in advanced non-small cell lung cancer

Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review

Temporal trends in online searches related to COVID-19 vaccine safety: A digital infodemiology study

Clonazepam Recall Grows Over Potentially Life-Threatening Label Error

Eliminate Clozapine REMS, FDA Panels Say

Implementation Status and Challenges of Pharmacovigilance Program in Ethiopia: A Mixed-Methods Study

Deprescribing oral antidiabetics in elderly patients: Do electronic leaflets across the world address it?

Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques

Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative Study

Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis

Implementation Status and Challenges of Pharmacovigilance Program in Ethiopia: A Mixed-Methods Study

Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review

Emerging Technologies in the Pharmaceutical Supply Chains: A Systematic Review of Industry 5.0 Challenges

Boletín sobre Seguridad de Medicamentos de Uso Humano. Octubre de 2024

Exclusive-US FDA Finds Widely Used Asthma Drug Impacts the Brain

Governance of artificial intelligence and machine learning in pharmacovigilance: what works today and what more is needed?

Side Effects of GLP-1 Drugs: What Doctors Should Know

Integrating Big Data, Artificial Intelligence, and motion analysis for emerging precision medicine applications in Parkinson’s Disease

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

How to Stop Bone Loss After Denosumab? No Easy Answers

The Influence of Internet-Derived Misinformation on Medical Treatment Decisions: A Social Learning Perspective

Patient-centric decision-making in supplements intake and disclosure in clinical practice: a novel SIDP-12 tool to prevent drug–supplement interaction

Retrospective analysis of survival and safety of bevacizumab biosimilar and original drug combination chemotherapy in non-small cell lung cancer

The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems

Web application for assisting non-dermatology physicians in learning and managing patients with common cutaneous adverse drug reactions: a multicenter randomized controlled trial

A Review on In Details of the Pharmacovigilance

Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database

Safety Profile of Statins for Post-Marketing Adverse Cardiovascular Events: A Real-World Pharmacovigilance Analysis

Mendelian randomization and pharmacovigilance analyses reveal the causal relationship between antidiabetic drugs and psychiatric disorders

Polygenic risk score for drug-induced long QT syndrome: independent validation in a real-world patient cohort

Efficacy and safety of traditional Chinese medicine for the treatment of epilepsy by wind quenching and phlegm resolving: A systematic review and meta-analysis

The Post-Acute Covid-Vaccination Syndrome in the light of Pharmacovigilance

A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease

Differences in Drug Shortages in the US and Canada

Ensuring Virtual Vigilance in Decentralized Clinical Trials

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

Untapped Potential? Representativeness in Pragmatic Clinical Trials

Inappropriate antibiotic prescription for acute tonsillitis in low- and middle-income countries (LMICs): a systematic review and meta-analysis protocol